The related cell phenotype is characterised through various detection methods, e.g. immunohistochemistry (IHC), as showing a high concentration of the intramembrane receptor HER2, while the cancer tissue phenotype has been described as 'poorly differentiated' and associated with a poor prognosis. This evidence concerns the gene ERBB2 and cancer.